Vitamin D5

Izvor: Wikipedija
Prijeđi na navigaciju Prijeđi na pretragu
Vitamin D5
IUPAC ime
Identifikacija
CAS registarski broj 71761-06-3
PubChem[1][2] 9547700
ChemSpider[3] 7826639 DaY
Jmol-3D slike Slika 1
Svojstva
Molekulska formula C29H48O
Molarna masa 412,69

 DaY (šta je ovo?)   (verifikuj)

Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje (25 °C, 100 kPa) materijala

Infobox references

Vitamin D5 je oblik vitamina D.

Analogna jedinjenja su predložena za upotrebu kao antitumorski agensi.[4][5][6]

Reference[uredi | uredi kod]

  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Mehta RG, Moriarty RM, Mehta RR, et al. (February 1997). „Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5”. J. Natl. Cancer Inst. 89 (3): 212–8. DOI:10.1093/jnci/89.3.212. PMID 9017001. 
  5. Murillo G, Mehta RG (October 2005). „Chemoprevention of chemically-induced mammary and colon carcinogenesis by 1alpha-hydroxyvitamin D5”. J. Steroid Biochem. Mol. Biol. 97 (1-2): 129–36. DOI:10.1016/j.jsbmb.2005.06.008. PMID 16051482. 
  6. Mehta RG (October 2004). „Stage-specific inhibition of mammary carcinogenesis by 1alpha-hydroxyvitamin D5”. Eur. J. Cancer 40 (15): 2331–7. DOI:10.1016/j.ejca.2004.05.025. PMID 15454260. 

Vidi još[uredi | uredi kod]